Intuitive Surgical Reports New Employee Option Grants for March 2013

Wed Mar 13, 2013 5:48pm EDT

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130313:nGNXUXJABa

SUNNYVALE, Calif., March 13, 2013 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG) today
reported that equity awards approved by the Compensation Committee of the Board of Directors,
which consists entirely of Independent Directors, were made to 56 new employees. Pursuant to
NASDAQ Marketplace Rule 5635(c)(4), the equity awards were granted under the Intuitive Surgical,
Inc. 2009 Commencement Incentive Plan, which the Board of Directors of Intuitive Surgical, Inc.
adopted for the granting of equity awards to new employees. In accordance with NASDAQ rules, these
grants were made under an equity incentive plan without shareholder approval. NASDAQ rules require
a public announcement of equity awards to be made under this type of plan. 56 employees were
granted options to purchase an aggregate of 15,092 shares of the Company's common stock. The
options vest over four years and expire in 10 years assuming continued employment. No officers
received any award under this plan. The exercise price for the option shares granted is $513.18
which was the closing price of Intuitive Surgical, Inc.'s common stock on the NASDAQ Global Market
as such price was reported by NASDAQ on March 7, 2013. The Company's policy is to issue stock
option grants to new employees on the fifth business day of every calendar month. This
announcement complies with the applicable NASDAQ rule requiring disclosure of such an inducement
grant.

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. (Nasdaq:ISRG), headquartered in Sunnyvale, California, is the global
technology leader in robotic-assisted, minimally invasive surgery. Intuitive Surgical develops,
manufactures and markets robotic technologies designed to improve clinical outcomes and help
patients return more quickly to active and productive lives. The Company's mission is to extend
the benefits of minimally invasive surgery to the broadest possible base of patients. Intuitive
Surgical - Taking surgery beyond the limits of the human hand.

About the da Vinci Surgical System

The da Vinci System is a breakthrough surgical platform designed to enable complex surgery using a
minimally invasive approach. The da Vinci System consists of an ergonomic surgeon console, a
patient-side cart with four interactive robotic arms, a high-performance vision system and
proprietary EndoWrist instruments. Powered by state-of-the-art robotic and computer technology,
the da Vinci System is designed to scale, filter and seamlessly translate the surgeon's hand
movements into more precise movements of the EndoWrist instruments. The net result is an intuitive
interface with breakthrough surgical capabilities. By providing surgeons with superior
visualization, enhanced dexterity, greater precision and ergonomic comfort, the da Vinci Surgical
System makes it possible for more surgeons to perform minimally invasive procedures involving
complex dissection or reconstruction. This ultimately has the potential to raise the standard of
care for complex surgeries, translating into numerous potential patient benefits, including less
pain, a shorter recovery and quicker return to normal daily activities.

Intuitive, da Vinci, da Vinci S, da Vinci Si, InSite and EndoWrist are trademarks or registered
trademarks of Intuitive Surgical, Inc.

For more information, please visit the company's web site at www.intuitivesurgical.com
http://www.globenewswire.com/newsroom/ctr?d=10025108&l=7&a=www.intuitivesurgical.com&u=http%3A%2F%2Fwww.intuitivesurgical.com
.

This news release was distributed by GlobeNewswire, www.globenewswire.com
http://www.globenewswire.com/newsroom/ctr?d=10025108&l=8&a=www.globenewswire.com&u=http%3A%2F%2Fwww.globenewswire.com

CONTACT: Intuitive Surgical, Inc.
         Investor Relations
         408-523-2161

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.